Home » Topics » BioWorld Science

BioWorld Science
RSS

Topline results announced from phase I study of ZYN-001 THC-prodrug patch

July 6, 2018

MR-438 peptidomimetic presented as a new radiosensitizing agent in medulloblastoma

July 6, 2018

[89]Zr-DFO-dinutuximab as novel radiotracer for selective detection of GD2-positive tumors

July 6, 2018

NOVA2 or DDX6 mutations alter RNA metabolism leading to intellectual disability

July 6, 2018

Serum netrin-1, a potential early biomarker for impaired fasting glucose and type 2 diabetes

July 6, 2018

CYP11B1 enzyme, a potential predictive biomarker for healing failure in diabetic foot ulcers

July 6, 2018

CB-4211 potentiates insulin effects on fatty acid metabolism and glucose homeostasis

July 6, 2018

IDMC clears phase III study of Tedopi in NSCLC to continue

July 5, 2018

Phase II study of pacritinib in myelofibrosis cleared to continue by IDMC

July 5, 2018

Immutep submits IND to begin phase II study of eftilagimod with Keytruda

July 5, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...